PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575767
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575767
Report Overview
Global Butterfly Needle Sets Market reached US$ 220.48 million in 2023 and is expected to reach US$ 379.04 million by 2031, growing at a CAGR of 7.1% during the forecast period 2024-2031.
A butterfly needle, also known as a scalp vein set or winged infusion set, is a tool used to take blood from a vein or give IV medication through it. It consists of a narrow needle, two flexible wings, a clear flexible tube, and a connector.
It is widely used to treat contracture patients and pediatric kids by collecting blood samples and providing quick small infusion solutions. It is primarily used for venipuncture (also known as winged infusion or butterfly set).
Market Dynamics: Drivers & Restraints
Increase in the prevalence of chronic diseases
Butterfly needles are considered to be more precise and less painful than regular needles. As more patients with chronic diseases require long-term care, healthcare providers are more likely to use devices to improve patient comfort and minimize concern. The aging population is more vulnerable to chronic diseases, resulting in increased demand for medical devices such as butterfly needle sets, as elderly people often need regular medical tests.
For instance, according to the report by the Centers for Disease Control and Prevention in 2022, it is estimated that around 6 in 10 adults in the US are suffering from chronic diseases and among them 4 in 10 adults suffer from more than two chronic diseases at a time. This increases the need for butterfly needle sets for the procedures required during the treatment. Thus, the above factors are expected to drive the market growth.
High cost of the butterfly needles
Compared to standard syringes and needles, butterfly needles are often more costly, particularly when it comes to sophisticated features like safety needles or pre-filled syringes. This can be a deterrent for consumers and healthcare professionals who are concerned about costs, especially in areas with little resources. Thus, it can hinder the market growth.
Market Segment Analysis
The global butterfly needle sets market is segmented based on the gauge type, applications, end-users and region.
The 25G butterfly needles segment is expected to dominate the market share
25G butterfly needles are expected to hold the dominant position in the market share due to their advantages and applications over the other types. Compared to lesser gauge needles (e.g., 22G, 21G), 25G needles have a smaller diameter, which makes them thinner and may cause less discomfort during insertion, particularly for youngsters or patients with delicate veins.
Due to their tiny size, they cause less tissue damage at the puncture site, which promotes quicker healing and may lessen swelling or bruises. Patients with thin or frail veins are best served by 25G needles since bigger needles may be difficult to place or may even induce vein collapse. For operations like certain blood draws or injections that need slower blood flow management, a smaller size could be desirable.
Because of the reduced size, there is less chance of unintentional vein injury during operations due to improved control and precision. Thus, the above factors are increasing the demand for 25G butterfly needles and are expected to hold the segment in the dominant position in the forecast period.
Market Geographical Share
North America is expected to hold a significant position in the butterfly needle sets market share
North America is expected to hold a dominant position in the market growth. There are several hospitals, clinics, and other medical institutions in the region that are furnished with cutting-edge tools and technology. The market is growing because of this strong infrastructure, which leads to an increase in the use of butterfly needle-based medical operations and treatments.
Chronic diseases like cancer and diabetes are very common in North America, which makes the use of butterfly needles in procedures increasingly common. For instance, according to the American Cancer Society, it is estimated that there will be around 2 million cancer cases in the US in 2024. It is estimated that around 5,500 cancer cases will be diagnosed each day. Thus, the above factors are expected to hold the region in the dominant position in the market share.
21G Butterfly Needles
23G Butterfly Needles
25G Butterfly Needles
Others
Delivery of Medications
IV Rehydration
Blood Transfusion
Others
Hospitals
Blood Banks
Pathology Labs
Others
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the market include Nipro Corporation, Medline Industries, Terumo Corporation, Cardinal Health, Becton, Dickinson and Company, Kawasumi Laboratories America, ZIBO ECONST MEDICAL INSTRUMENT CO., LTD., Al Shifa Medical Products Co, Vitaimed Instrument Co., Ltd., McKesson Medical-Surgical Inc. among others.
To visualize the global butterfly needle sets market segmentation based on the gauge type, applications, end-users, and region as well as understand key commercial assets and players.
identify commercial opportunities by analyzing trends and co-development.
excel data sheet with numerous data points of the butterfly needle sets market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global butterfly needle sets market report would provide approximately 55 tables, 58 figures and 180 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies